ISSN:
1432-0428
Keywords:
Key words Diabetes mellitus, rat, advanced glycation end-products, aminoguanidine, vascular permeability, albuminuria.
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary Advanced glycation end-product-formation is thought to play a role in the development of diabetic angiopathy. By altering the structure of different extracellular matrix components advanced glycation end-products might affect vascular and glomerular permeability. In this study we investigated the effect of treatment with an inhibitor of advanced glycation end-product-formation, aminoguanidine, on vascular permeability and the development of albuminuria in streptozotocin-induced diabetic rats. Male Wistar Rp rats were randomized into a control group, a diabetic group, and an aminoguanidine-treated diabetic group. After 8 weeks, 24-h urine collections were taken and rats were implanted with an arterial and a venous catheter. Mean arterial blood pressure was determined by intra-arterial measurement. Regional albumin clearances were assessed in the eye, ileum, lung, skeletal muscle and skin using an isotope technique. Mean arterial pressure in the diabetic group was significantly lower in the control and aminoguanidine-treated groups (p 〈0.02). Regional albumin clearances were significantly increased in all tissues of diabetic rats compared to control rats (p 〈0.05). Aminoguanidine treatment of diabetic rats resulted in a significant decrease of regional albumin clearance in all tissues except the lung (p 〈0.05, lung p =0.07). The development of albuminuria in diabetic rats however, was not affected by aminoguanidine. [Diabetologia (1994) 37: 10–14]
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/s001250050065
Permalink
